Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-11-02 Transaction in Own Shar…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
6-K
Transaction in Own Shares Classification · 100% confidence The document is a Form 6-K filed with the SEC by PureTech Health plc, reporting on the company's share repurchase program activity during October 2023. It details daily purchases of the company's own shares under the program, including quantities and prices, and references regulatory compliance with UK and EU rules. The content focuses on the company's transactions in its own shares, specifically buybacks, and does not contain financial statements or earnings data. The document length is 6721 characters, which is sufficient to provide detailed transaction data. Given the detailed reporting of share repurchases, this fits the category of Transaction in Own Shares (POS).
2023-11-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (1 November 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The RNS header confirms it is a regulatory announcement, but the content is specific enough to map to POS.
2023-11-02 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (31 October 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance), which maps to the filing code POS. The presence of the RNS Number and the LSE distribution information confirms it is a regulatory disclosure, but the content is specific enough to use the dedicated code.
2023-11-01 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: 'Transaction in Own Shares'. It details the purchase of ordinary shares as part of a 'Share Buyback Programme' on a specific date (30 October 2023), including volume, price, and the resulting treasury share count. This directly corresponds to the definition of 'Transaction in Own Shares' (POS).
2023-10-31 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "PureTech Health PLC ... Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (27 October 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of a Transaction in Own Shares (Share Repurchase/Issuance). The filing code for this activity is POS.
2023-10-30 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is explicitly titled 'Transaction in Own Shares' and details the purchase of ordinary shares by PureTech Health PLC as part of its 'Share Buyback Programme'. It provides specific transaction dates, volumes, and prices, and concludes with the updated total shares in issue and treasury. This directly corresponds to the definition of a 'Transaction in Own Shares' filing, which maps to the code POS (Share Repurchase/Issuance). The presence of the RNS Number and the LSE/FCA context confirms it is a regulatory disclosure, but the specific content points overwhelmingly to POS.
2023-10-27 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.